Privacy Policy
Cumulus Media, Inc. Internet Privacy Policy
Stay updated with breaking news from Cumulus Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study looking at the feasibility of using repeated sampling of validated digital measures at home, in patients with early-stage Alzheimer’s Disease (AD), has completed enrollment for a multi-site study.
Oxford and Cambridge Among Sites Participating in CNS-101 Validation Study BELFAST, Northern Ireland and CAMBRIDGE, Mass., May 31, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus;
/PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care...